New Zealand markets closed

Ginkgo Bioworks Holdings, Inc. (DNA)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
0.3702+0.0336 (+9.98%)
At close: 04:00PM EDT
0.3699 -0.00 (-0.08%)
After hours: 07:59PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 824.95M
Enterprise value 219.01M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)3.49
Price/book (mrq)0.84
Enterprise value/revenue 1.05
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.14
52-week change 3-85.26%
S&P500 52-week change 318.96%
52-week high 32.5200
52-week low 30.2640
50-day moving average 30.4558
200-day moving average 31.0918

Share statistics

Avg vol (3-month) 359.97M
Avg vol (10-day) 348.86M
Shares outstanding 51.73B
Implied shares outstanding 62.23B
Float 81.34B
% held by insiders 16.42%
% held by institutions 172.70%
Shares short (15 Jul 2024) 497.24M
Short ratio (15 Jul 2024) 41.21
Short % of float (15 Jul 2024) 47.76%
Short % of shares outstanding (15 Jul 2024) 44.36%
Shares short (prior month 14 Jun 2024) 4238.22M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)-469.12%

Management effectiveness

Return on assets (ttm)-21.76%
Return on equity (ttm)-65.81%

Income statement

Revenue (ttm)208.7M
Revenue per share (ttm)0.11
Quarterly revenue growth (yoy)-53.00%
Gross profit (ttm)N/A
EBITDA -630.63M
Net income avi to common (ttm)-853.81M
Diluted EPS (ttm)-0.4300
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)840.44M
Total cash per share (mrq)0.38
Total debt (mrq)234.5M
Total debt/equity (mrq)23.75%
Current ratio (mrq)5.34
Book value per share (mrq)0.46

Cash flow statement

Operating cash flow (ttm)-294.17M
Levered free cash flow (ttm)-159.04M